Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy

The treatment of rheumatoid arthritis (RA) has been transformed with the introduction of biologic disease modifying anti-rheumatic drugs (bDMARD) and more recently, targeted synthetic DMARD (tsDMARD) therapies in the form of janus-kinase inhibitors. Nevertheless, response to these agents varies such...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouboussad, Lylia, Burska, Agata N., Melville, Andrew, Buch, Maya H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433846/
https://www.ncbi.nlm.nih.gov/pubmed/30941350
http://dx.doi.org/10.3389/fmed.2019.00045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433846/
https://www.ncbi.nlm.nih.gov/pubmed/30941350
http://dx.doi.org/10.3389/fmed.2019.00045

Ejemplares similares